Firm at a glance
Welsh, Carson, Anderson & Stowe is a platform private equity firm founded in 1979 and headquartered in New York, NY, per its own website [S1].
What they buy
The firm’s portfolio reflects a concentrated focus on two sectors: technology and healthcare [S2]. Within technology, observed investments span financial technology, payments, human capital management, supply chain management, and data services [S2]. Healthcare investments include care delivery platforms, health information technology, pharmaceutical value chain services, and payor services [S2].
Portfolio
Healthcare – Care Delivery
CenterWell Senior Primary Care, Concentra, Constitution Surgery Alliance, Emerus, Kindred at Home, Select Medical, United Musculoskeletal Partners, US Anesthesia Partners [S2]
Healthcare – Pharma Value Chain
Abzena, AssistRx, Norstella, Shields [S2]
Healthcare – Payor Services & Risk-Based Care
InnovAge, Liberty Dental Plan, naviHealth [S2]
Healthcare – HCIT
ImageTrend, Practice Suite [S2]
Healthcare – Other
Leiters, Valtruis [S2]
Technology – FinTech
Bisys, Clearwater Analytics, EquiLend, Fiserv [S2]
Technology – Payments
GlobalCollect, TransFirst [S2]
Technology – Data & Information Services
Alliance Data [S2]
Technology – HCM
Ceridian [S2]
Technology – SCM
Avetta, TrueCommerce [S2]
Technology – Real Estate
AIA Contract Documents, Green Street [S2]
Technology – EdTech
Absorb [S2]
Technology – GovTech
GovCIO [S2]
Technology – Government, Risk and Compliance
Simeio [S2]
Technology – Other
Alert Logic, Asurion, EnableComp, Headstrong, Identifix, Kiniciti, LINQ, Owl, Quickbase, Revel Systems, Triple Point Technology [S2]
Recent activity (last 24 months)
* December 10, 2025: Exit of Lumexa Imaging [S3]
* August 11, 2025: Add-on acquisition of SoldierPoint Digital Health, LLC [S3]
* July 29, 2025: Add-on acquisition of Trading Apps [S3]
How this firm fits a seller
Welsh Carson’s portfolio demonstrates a multi-decade track record in both technology and healthcare sectors, with approximately two add-on acquisitions completed in the trailing 12 months as of mid-2026 [S2][S3]. The firm has raised over $31 billion across 14 funds as of June 2026, indicating substantial capital availability [S1]. For owner-operators in healthcare services, health IT, financial technology, or B2B software, the firm’s sector concentration and history of building platforms through acquisitions may represent a relevant fit. The firm maintains offices in New York and San Francisco [S1].
Sources
[S1] https://wcas.com/firm/ (as of 2026-06-20)
[S2] https://wcas.com/firm/investments/ (as of 2026-06-20)
[S3] https://wcas.com/news-perspectives/ (as of 2025-12-10)
Frequently asked questions
Does Welsh, Carson, Anderson & Stowe buy healthcare businesses?
Yes, approximately half of the firm’s observed portfolio consists of healthcare investments [S2]. These include care delivery platforms such as US Anesthesia Partners and Select Medical, health IT companies like ImageTrend and Practice Suite, and pharmaceutical value chain services including Norstella and Shields [S2].
What companies has Welsh, Carson, Anderson & Stowe acquired recently?
Recent disclosed activity includes the add-on acquisition of SoldierPoint Digital Health in August 2025 and Trading Apps in July 2025 [S3]. The firm also completed an exit of Lumexa Imaging in December 2025 [S3].
Where is Welsh, Carson, Anderson & Stowe based and how big is the firm?
The firm is headquartered in New York, NY, with an additional office in San Francisco, CA [S1]. Welsh Carson has raised over $31 billion across 14 funds as of June 2026 [S1].
Is Welsh, Carson, Anderson & Stowe still actively acquiring?
Yes, the firm completed two add-on acquisitions in the second half of 2025, indicating ongoing investment activity [S3].
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.